Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment.
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment have been produced by the Japan Gastroenterological Endoscopy Society in collaboration with the Japan Circulation Society, the Japanese Society of Neurology, the Japan Stroke Society, the Japanese Society on Thrombosis and Hemostasis and the Japan Diabetes Society. Previous guidelines from the Japan Gastroenterological Endoscopy Society have focused primarily on prevention of hemorrhage after gastroenterological endoscopy as a result of continuation ofantithrombotic therapy, without considering the associated risk of thrombosis. The new edition of the guidelines includes discussions of gastroenterological hemorrhage associated with continuation of antithrombotic therapy, as well as thromboembolism associated with withdrawal of antithrombotic therapy.
The Japan Gastroenterological Endoscopy Society, Tokyo, Japan.
Kazuma
K
Fujimoto
Mitsuhiro
M
Fujishiro
Mototsugu
M
Kato
Kazuhide
K
Higuchi
Ryuichi
R
Iwakiri
Choitsu
C
Sakamoto
Shinichiro
S
Uchiyama
Atsunori
A
Kashiwagi
Hisao
H
Ogawa
Kazunari
K
Murakami
Tetsuya
T
Mine
Junji
J
Yoshino
Yoshikazu
Y
Kinoshita
Masao
M
Ichinose
Toshiyuki
T
Matsui
D001241:Aspirin / Q000627:therapeutic use; D000075202:Contraindications; D016099:Endoscopy, Gastrointestinal / Q000009:adverse effects / Q000592:standards*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007564:Japan; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016730:Program Development; D012307:Risk Factors; D012955:Societies, Medical
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
anticoagulant; antiplatelet agent; gastroenterological endoscopic examination and treatment; gastroenterological hemorrhage; thromboembolism